SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ami Organics shines on signing MoU with global manufacturer of Electrolytes

22 Dec 2023 Evaluate

AMI Organics is currently trading at Rs. 1190.30, up by 45.70 points or 3.99% from its previous closing of Rs. 1144.60 on the BSE.

The scrip opened at Rs. 1184.55 and has touched a high and low of Rs. 1235.00 and Rs. 1182.35 respectively. So far 55106 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1387.50 on 24-Aug-2023 and a 52 week low of Rs. 844.95 on 01-Feb-2023.

Last one week high and low of the scrip stood at Rs. 1235.00 and Rs. 1023.10 respectively. The current market cap of the company is Rs. 4398.38 crore.

The promoters holding in the company stood at 38.93%, while Institutions and Non-Institutions held 13.10% and 47.97% respectively.

Ami Organics has signed a non-binding memorandum of understanding (MoU) with a global manufacturer of Electrolytes for manufacturing of electrolytes for battery cells and allied materials in Gujarat, India. In furtherance to this, the company will also sign an MOU with Government of Gujarat for investment amounting up to Rs 300 crore for set up of dedicated manufacturing facility for electrolytes business in the state of Gujarat, in the upcoming Vibrant Gujarat Summit 2024.

The MOU reflects the Ami Organics strategic foresights in aligning with the transformative industry trends in battery chemicals space. This product aligns with the Government’s Make in India initiative. The comapny is committed to fostering innovative solutions in the Energy storage device sector while contributing towards environment sustainability.

Ami Organics is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

Acutaas Chemicals Share Price

2361.75 16.10 (0.69%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×